Optogenetics Global Market Report 2024

“Optogenetics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on optogenetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for optogenetics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The optogenetics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Lasers; Actuators; Sensors
• 2) By Application: Neuroscience; Behavioral Tracking; Retinal Disease Treatment; Other Applications
• 3) By End User: Hospitals And Clinics; Diagnostics Centers; Research Centers; Other End Users
• Companies Mentioned: Elliot Scientific Ltd.; Shanghai Laser & Optics Century Co. Ltd.; GenSight Biologics; Danaher Corporation; Coherent Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Optogenetics is a comprehensive technique that combines optical systems and genetic engineering technologies to precisely regulate and monitor biological processes within cells, groups of cells, tissues, or organs with high temporal and spatial resolution. This technique is primarily used to monitor and control the physiological activity of neurons and other cell types, employing light sensors. Optogenetics plays a crucial role in identifying the underlying causes of various conditions such as Parkinson's disease, memory disorders, anxiety, addiction issues, mood swings, and other ailments.

The main products associated with optogenetics include lasers, actuators, and sensors. A laser is a device that emits light through a process of optical amplification at specific wavelengths, producing a very narrow beam of light. These products find various applications in neuroscience, behavioral tracking, retinal disease treatment, and other related fields. End-users of optogenetics products include hospitals and clinics, diagnostics centers, research centers, and other institutions involved in scientific and medical research.

The optogenetic market research report is one of a series of new reports from The Business Research Company that provides optogenetics market statistics, including optogenetics industry global market size, regional shares, competitors with a optogenetics market share, detailed optogenetics market segments, market trends and opportunities, and any further data you may need to thrive in the optogenetics industry. This optogenetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The optogenetics market size has grown rapidly in recent years. It will grow from $31.9 billion in 2023 to $36.81 billion in 2024 at a compound annual growth rate (CAGR) of 15.4%. The growth observed in the historical period can be attributed to factors such as the rise in neurological disorders, increased funding in life sciences, advancements in drug discovery and development, the mapping of neural circuits, the application of optogenetics in drug screening, and progress in neurophotonics.

The optogenetics market size is expected to see rapid growth in the next few years. It will grow to $63.33 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The anticipated growth in the forecast period can be attributed to factors such as the expansion of therapeutic applications, increased focus on clinical trials and translation, extending applications into non-neuronal cells, the utilization of optogenetics in brain-machine interfaces, and the development of novel light-sensitive proteins. Major trends expected in this period include advancements in optogenetic tools and technologies, collaborations with pharmaceutical companies, the integration of optogenetics in drug discovery and development, the expansion of applications into non-neural cell types, and the integration of optogenetics with other imaging technologies.

The optogenetics market is anticipated to experience growth due to the rising prevalence of Parkinson's disease (PD) and epilepsy worldwide. Parkinson's disease is characterized by degeneration in the brain, leading to motor symptoms such as slow movement, tremors, rigidity, and imbalance, along with cognitive decline, mental health issues, sleep disturbances, pain, and sensory problems. Optogenetic therapy employs proteins responsive to specific light wavelengths, produced through gene therapy techniques, to treat Parkinson's disease by either activating or deactivating these proteins with specific types of light, ultimately normalizing brain function. In December 2022, The Parkinson's Foundation reported a significant increase in annual PD diagnoses to nearly 90,000, up from the previous estimate of 60,000. The number of individuals living with PD in the U.S. is expected to rise to 1.2 million by 2030 from 930,000 in 2020, driving the growth of the optogenetics market.

The optogenetics market is also fueled by increased funding for neuroscience research, which involves the scientific study of the nervous system, including the brain and peripheral nerves. Optogenetics, a cutting-edge technique in neuroscience, utilizes light to precisely control and manipulate specific neurons in living tissues, providing researchers with a powerful tool to understand neural circuits. In March 2023, the National Institutes of Health (NIH) reported approximately $11.3 billion in funding for neuroscience in fiscal year 2022, with projections indicating an expected increase to $12.1 billion by 2023. This increased funding is expected to drive the growth of the optogenetics market.

A prevailing trend in the optogenetics market is the emphasis on developing innovative systems, a strategy gaining traction among major companies in the industry. These companies are actively engaged in creating advanced tools and systems for optogenetics, incorporating state-of-the-art technologies to maintain their market standing. For instance, in June 2022, Bruker Corporation, a prominent US-based manufacturer of optogenetic tools, introduced NeuraLight 3D Ultra. This innovative product is an enhanced 3D holographic stimulation module designed to support cutting-edge neuroscience and optogenetics research applications, particularly tailored for use with Bruker's Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra facilitates in-depth functional research on neural networks and brain computation through its advanced 3D holographic photostimulation capabilities.

Major players in the optogenetics market are also directing their efforts towards the development of advanced products, with a focus on three-photon (3P) imaging solutions, aiming to gain a competitive edge and boost revenue. The three-photon imaging solution represents an integrated and versatile ultrafast laser system meticulously crafted for advanced three-photon imaging in neuroscience research. Additionally, it offers functionalities for two-photon photostimulation and imaging in optogenetics applications. For instance, in June 2022, Coherent, Inc., a leading US-based company specializing in laser equipment, launched the Monaco 1300-an all-in-one ultrafast 1300 nm light source. This cutting-edge device is specifically designed for three-photon (3P) imaging, featuring a switchable secondary output at 1035 nm to cater to two-photon (2P) photostimulation and imaging applications. The Monaco 1300, a single-box ultrafast laser, is engineered for 3-photon microscopy at 1300 nm and 2-photon optogenetics at 1035 nm, providing options for average power (1.5 W or 2.5 W), a pulse width of less than 50 fs, and various repetition rate choices (1, 2, or 4 MHz). This technological advancement equips researchers and businesses with advanced capabilities for precise imaging and optogenetic applications in the microscopy field. The comprehensive package of the Monaco 1300 includes the option for the widely favored Total Power Control (TPC) feature, allowing dynamic power attenuation and rapid optical gating on-the-fly.

In September 2021, Novartis AG, a Switzerland-based pharmaceutical giant, undertook the acquisition of Arctos Medical AG for an undisclosed amount. This strategic move is geared towards enhancing Novartis' presence in ophthalmology, strengthening its position in AAV-based gene therapy, and providing innovative treatments for patients experiencing severe vision loss. Arctos Medical, based in Switzerland, specializes in gene therapy and is particularly focused on optogenetic therapies.

Major companies operating in the optogenetics market report are Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems .

North America was the largest region in the optogenetics market in 2023. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the optogenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The optogenetics market consists of sales of optical cannula, fiber-optic cable, and light sources. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.